We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
+8.45%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$17.4M
AUM Growth
-$93.9M
Cap. Flow
-$95.1M
Cap. Flow %
-545.17%
Top 10 Hldgs %
70.1%
Holding
52
New
9
Increased
–
Reduced
16
Closed
27

Top Buys

1
AXNX
Axonics, Inc. Common Stock
AXNX
+$1.39M
2
ICLR icon
Icon
ICLR
+$947K
3
LH icon
Labcorp
LH
+$837K
4
EHC icon
Encompass Health
EHC
+$834K
5
PFE icon
Pfizer
PFE
+$477K

Top Sells

1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$15.5M
2
BRKR icon
Bruker
BRKR
+$6.93M
3
AZN icon
AstraZeneca
AZN
+$6.53M
4
ELV icon
Elevance Health
ELV
+$5.03M
5
TMO icon
Thermo Fisher Scientific
TMO
+$4.87M

Sector Composition

1 Healthcare 98.36%
2 Real Estate 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TXG icon
51
10x Genomics
TXG
$5.55B
– –
-71,044
Closed -$2.93M
VTYX
52
DELISTED
Ventyx Biosciences
VTYX
– –
-18,458
Closed -$641K
1 2
3

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Endurant Capital Management held 52 positions worth $17.4M, down 84% from $111M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Endurant Capital Management withdrew a net $95.1M in Q4 2023, closing 27 positions and reducing 16 holdings. Its most notable exit was Bruker, an estimated $6.93M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 95% a quarter earlier, followed by Real Estate.

Against the trend, Endurant Capital Management opened a new position in Axonics, Inc. Common Stock worth $1.55M.

  • Endurant Capital Management's largest Q4 2023 buy was Axonics, Inc. Common Stock: 24,871 shares worth $1.55M.
  • Endurant Capital Management's biggest Q4 2023 reduction was BioMarin Pharmaceuticals, cutting an estimated $15.5M.
  • Endurant Capital Management fully exited Bruker in Q4 2023, selling an estimated $6.93M.
  • Endurant Capital Management's ten largest holdings make up 70% of its $17.4M portfolio in Q4 2023.
  • Endurant Capital Management opened 9 new positions and closed 27 in Q4 2023.
  • Endurant Capital Management's portfolio value fell 84% quarter-over-quarter to $17.4M.

Based on Endurant Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.